Post by
Yajne on Jan 11, 2021 8:24pm
The elephant in the room
...will Peter draw some attention to HPQ in his Sidoti presentation, especially given their major contribution to Q4 guidance? They were hardly mentioned in the SNN presentation.
Comment by
paul0316 on Jan 11, 2021 8:29pm
HPQ is a pretty huge elephant. One that PYR would love to watch it grow bigger. For obvious reasons. I'm hoping he talks about them this time. At the end of the day though, the samples will speak for themselves! Looking forward to a great year for PYR and HPQ!
Comment by
canyousayiii on Jan 11, 2021 8:36pm
Big boys will put HPQ on their "watch list". Without knowing names of partners or seeing many $ at this stage, they will not take the words of the two CEOs as a gimme. I think PYR needs to draw more attention on where their commercial or near-commercial products are heading. JMHO.
Comment by
canyousayiii on Jan 11, 2021 9:55pm
Does anyone know how many employees PYR has?
Comment by
MidtownGuy on Jan 11, 2021 9:58pm
They have 70 employees. All the corporate details are listed on SEDAR under a file called "Annual Information Form" or AIF.
Comment by
Yajne on Jan 11, 2021 9:56pm
MtG, while I might agree to the risk mitigation aspect, the fact that PYR's eps guidance relies hugely on the HPQ contribution suggests to me that Peter might need to address it...even if it's only in the Q&A's following presentation. The HPQ eps impact on guidance is solely why I've labelled it "the elephant in the room"
Comment by
canyousayiii on Jan 11, 2021 10:10pm
Analysts can figure it out from the financial statements or the other giveaway is that you cant make more profit than revenues. I am pretty sure any longer term analysis will focus on operational revenues. Flactuations caused by a volatile microcap market is not something that they will hang their hat on. They will have to eventually figure out what kind of revenues willbbe coming out of HPQ.